Dr. Saseen is an Associate Professor of Clinical Pharmacy and Family Medicine at the University of Colorado Denver. He is a Board Certified Pharmacotherapy Specialist with added qualifications in cardiology, is certified as a Clinical Lipid Specialist, and is a Fellow of the American College of Clinical Pharmacy. Dr. Saseen received both his B.S. pharmacy degree and PharmD degree from the State University of New York at Buffalo and then completed an ambulatory care research fellowship at the University of Illinois at Chicago. In his current position, Dr. Saseen practices as a clinical pharmacy specialist at University of Colorado’s Family Medicine Center, and educates pharmacy and medical students. His research and other scholarly endeavors focus on cardiovascular pharmacotherapy. Dr. Saseen is on the board of regents for the American College of Clinical Pharmacy, is a member of the Board of Directors for the National Lipid Association’s Accreditation Council for Clinical Lipidology, and is a member of the Board of Directors and Editorial Board for the journal Pharmacotherapy. He has won several teaching awards, most recently was the recipient of the Doctor of Pharmacy Class of 2009’s Outstanding Instructor Award in May of 2008.
PRESENTER:
Click the plus sign to see more detailed information about each speaker.
Dr. Saseen is an Associate Professor of Clinical Pharmacy and Family Medicine at the University of Colorado Denver. He is a Board Certified Pharmacotherapy Specialist with added qualifications in cardiology, is certified as a Clinical Lipid Specialist, and is a Fellow of the American College of Clinical Pharmacy. Dr. Saseen received both his B.S. pharmacy degree and PharmD degree from the State University of New York at Buffalo and then completed an ambulatory care research fellowship at the University of Illinois at Chicago. In his current position, Dr. Saseen practices as a clinical pharmacy specialist at University of Colorado’s Family Medicine Center, and educates pharmacy and medical students. His research and other scholarly endeavors focus on cardiovascular pharmacotherapy. Dr. Saseen is on the board of regents for the American College of Clinical Pharmacy, is a member of the Board of Directors for the National Lipid Association’s Accreditation Council for Clinical Lipidology, and is a member of the Board of Directors and Editorial Board for the journal Pharmacotherapy. He has won several teaching awards, most recently was the recipient of the Doctor of Pharmacy Class of 2009’s Outstanding Instructor Award in May of 2008.
Recommend therapy that effectively implements the new dyslipidemia guidelines in specified cases.
Recommend therapy that effectively implements the new hypertension guidelines in specified cases.
Summarize issues surrounding the latest evidence and guidelines evaluating the management of hypertension and dyslipidemia.